{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:34:34Z","timestamp":1759336474198},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,4,21]],"date-time":"2002-04-21T00:00:00Z","timestamp":1019347200000},"content-version":"vor","delay-in-days":79,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> The American cutaneous forms of leishmaniasis include immune\u2010responder individuals with localised cutaneous leishmaniasis (LCL) and non\u2010responder individuals with diffuse cutaneous leishmaniasis (DCL). Patients with intermediate or chronic cutaneous leishmaniasis (ICL) have increased morbidity due to the length of their illness, atypical forms and areas of compromise. In the present study, we evaluated the expression of the leukocyte antigens (CD4, CD8, CLA: cutaneous lymphocyte antigen, CD69, CD83 and CD1a) and cytokines (IFN\u2010\u03b3, IL\u20104, IL\u201010 and TGF\u2010\u03b21) in the lesions of patients with ICL (<jats:italic>n<\/jats:italic>\u2003=\u200318) using an immunocytochemical procedure. ICL results were compared with the information for LCL (<jats:italic>n<\/jats:italic>\u2003=\u200319) and DCL (<jats:italic>n<\/jats:italic>\u2003=\u20034). The numbers of CD4+ and CD8+ T cells in ICL were similar to those of LCL lesions, but significantly different (<jats:italic>P<\/jats:italic>\u2003\u2264\u20030.05) from DCL lesions. LCL lesions have about half the numbers of early activated CD69+ cells as ICL, but most are CLA+ skin homing memory T cells, whereas ICL lesions have the highest number of CD69+ T cells, but about one\u2010third of these cells expressed CLA. This suggests that the granuloma of ICL patients contains many activated T cells that are unprimed to cutaneous\u2010launched antigens, thus contributing to an aberrant immune response. In contrast, DCL granulomas presented the lowest numbers of activated CD69+ and CLA+ cells, associated with the characteristic tolerogenic state of these patients. The immunolocalisation of cytokines showed a mixed cytokine pattern in ICL lesions with many positive cells for IL\u201010, TGF\u2010\u03b21, IL\u20104 and IFN\u2010\u03b3, with a preponderance of the first two, and different from the prevalent Th1 and Th2 responses associated with LCL and DCL lesions, respectively. CD1a+ Langerhans cells were decreased (<jats:italic>P<\/jats:italic>\u2003\u2264\u20030.05) in both ICL (271\u2003\u00b1\u200315 cells\/mm<jats:sup>2<\/jats:sup>) and DCL (245\u2003\u00b1\u200319 cells\/mm<jats:sup>2<\/jats:sup>) as compared to LCL (527\u2003\u00b1\u200354 cells\/mm<jats:sup>2<\/jats:sup>) epidermis. The percentage of IL\u201010+ epidermal Langerhans cells in ICL (33.69), from the total CD1a+ population, was higher than in LCL (17.45). In addition, fewer CD83+ primed Langerhans cells were present in ICL epidermis. The diminished participation of epidermal Langerhans cells, causing a defective signalling by the epidermis, in ICL lesions may account for the tissue\u2010damaging state observed in these patients.<\/jats:p>","DOI":"10.1034\/j.1600-0625.2002.110104.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T20:27:17Z","timestamp":1047414437000},"page":"34-41","source":"Crossref","is-referenced-by-count":40,"title":["Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion"],"prefix":"10.1111","volume":"11","author":[{"given":"N.\u2003L.","family":"Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Zerpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.\u2003V.","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Convit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.\u2003J.","family":"Rondon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.\u2003J.","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(72)90306-9"},{"key":"e_1_2_6_3_2","first-page":"187","article-title":"Leprosy and leishmaniasis. Similar clinical immunological pathological models","volume":"11","author":"Convit J","year":"1974","journal-title":"Ethiop Med J"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.1.104"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1993.tb02796.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(93)90030-T"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90312-3"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1994.tb00261.x"},{"key":"e_1_2_6_9_2","first-page":"139","volume-title":"Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis. Austin: R.G. Landes Co","author":"Tapia F J","year":"1996"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90176-1"},{"key":"e_1_2_6_11_2","first-page":"355","article-title":"Cytoplasmic as opposed to surface Ia antigen expressed on human peripheral blood lymphocytes and monocytes","volume":"11","author":"Hofmann F M","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4269\/ajtmh.1988.38.608","article-title":"Leukocyte subsets in the granulomatous response produced after inoculation with Mycobacterium leprae\u2013 BCG in lepromatous patients","volume":"11","author":"Gross A","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_6_13_2","first-page":"479","volume-title":"\u2018The Langerhans Cells\u2019","author":"Tapia F J","year":"1988"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0001-706X(91)90078-X"},{"key":"e_1_2_6_15_2","unstructured":"ZerpaO D\u00edazN L CabreraMet al.Leishmaniasis cut\u00e1nea intermedia: Aspectos Cl\u00ednicos inmunol\u00f3gicos y parasitol\u00f3gicos.XIV Ibero Latin American Congress of Dermatology Malaga Spain June 1999."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(96)00036-3"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64756-6"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(99)00312-2"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12377706"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.4049\/jimmunol.159.12.6018","article-title":"Independent regulation of cutaneous lymphocyte\u2010associated antigen expression and cytokine synthesis phenotype during human CD4+ memory T cell differentiation","volume":"11","author":"Teraki Y","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.5.1483"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12613452"},{"key":"e_1_2_6_23_2","first-page":"500","article-title":"Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction","volume":"11","author":"C\u00e1ceres\u2010Dittmar G","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116341"},{"key":"e_1_2_6_25_2","first-page":"203","volume-title":"Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis.","author":"Cast\u00e9s M","year":"1996"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.4.617"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0625.2002.110104.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0625.2002.110104.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0625.2002.110104.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T14:15:11Z","timestamp":1697552111000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0625.2002.110104.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1034\/j.1600-0625.2002.110104.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0625.2002.110104.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}